SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

FULC

Fulcrum Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed3d 11h ago SEC0000919574-26-007765
Passive stake amendment
Actionable Insight • Neutral

Monitor for any new 13D or 13G filings from other holders that could indicate changing ownership dynamics. The exit by a passive manager is routine and does not alter the fundamental outlook.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Montanova Capital LLC and affiliated entities filed an amended Schedule 13G disclosing they no longer hold any shares of Fulcrum Therapeutics as of September 30, 2026, down from a prior stake. This complete exit by a passive investment manager removes a known holder but does not signal activist intent.

Key Financial Metrics

Stake
0%
Stake Value
$0.00
Investor
Montanova Capital, LLC
Investor Type
hedge fund

Key Facts

  • Montanova Capital, Averill Master Fund, and Aaron Cowen filed Amendment No. 3 to Schedule 13G on November 13, 2026
  • The filing reports 0 shares and 0% beneficial ownership as of September 30, 2026
  • The prior filing (not provided) had disclosed a non-zero stake; this amendment reflects a complete exit
  • The filing states securities were held in the ordinary course and not for control purposes
  • Fulcrum Therapeutics has a market cap of $286M and a normal daily move of 1.8%

Financial Impact

Complete exit by Montanova Capital; prior stake size not disclosed in this filing

ownership

Risk Factors

  • No material risk identified from this routine passive exit

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000919574-26-007765
Document: p15120066_ex-b.htm0000919574-26-007765
Document: 0000919574-26-007765-index-headers.html0000919574-26-007765
Document: 0000919574-26-007765-index.html0000919574-26-007765
Document: 0000919574-26-007765.txt0000919574-26-007765

Track record

23 reports on FULC

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +7.71% at T+60 after the Jul 15, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $3.72 Now $3.71 −0.27% settles Nov 18
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $3.73 Now $3.71 −0.40% settles Nov 17
  3. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $3.77 Now $3.71 −1.59% settles Nov 17
  4. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $3.77 Now $3.71 −1.59% settles Nov 17
  5. Nov 12, 20264d ago 425 Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
  6. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
  7. Nov 5, 202612d ago EFFECT Neutral 4/10 Entry $3.68 to $3.70 Now $3.71 +0.82% ▲ +0.54% +0.23% vs SPY
  8. Nov 3, 202613d ago S-4/A Neutral 5/10 Entry $3.74 to $3.77 Now $3.71 −0.80% ▲ +0.80% −0.85% vs SPY
  9. Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
  10. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 5h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026